International Silver, Inc.
ISLV News Today: Stay Updated with the Latest International Silver, Inc. News in Real Time
Find ISLV news now at Meyka AI. Stay informed with the latest International Silver, Inc. stocks updates, including price news, market analysis, and expert insights.
NEE Earnings Preview: NextEra Energy Q2 2026 on April 23
NextEra Energy earnings preview for April 23, 2026. EPS estimate $0.988, revenue $7.27B. Analyst consensus and what to watch.
IDN Insider Trade: CEO Lewis Bryan Sells 10,000 Shares April 22, 2026
Intellicheck CEO Lewis Bryan sold 10,000 shares at $8.51 per share on April 20, 2026. Total value: $85,145.
TMO Thermo Fisher Q2 2026 Earnings Preview April 23
Thermo Fisher (TMO) reports Q2 2026 earnings April 23. Analysts expect $5.20 EPS and $10.86B revenue. Stock rated B+ by Meyka AI.
TMO Thermo Fisher Earnings Preview April 23, 2026
Thermo Fisher (TMO) reports Q2 earnings April 23. Analysts expect $5.20 EPS and $10.86B revenue. Stock trades at $524.57.
3322.T Stock Surges 0.22% on Volume Spike in Tokyo Trading
Alpha Group Inc. (3322.T) trades on JPX with 0.22% gains. Technical analysis and market sentiment for this diversified Japanese tech stock.
GLOO Insider Buying: CEO Beck Arthur Acquires 2,800 Shares April 22, 2026
Beck Arthur, GLOO CEO, purchased 2,800 shares at $7.98 on April 20, 2026. Insider buying signal for Gloo Holdings.
EQT Logs Record $20 Billion Gain from Galderma as Q1 Assets Stay Flat
The global investment firm EQT AB has reported a major financial milestone as it logs a record $20 billion gain from its investment in Galderma. Despite this massive gain, the firm’s total assets under management remained largely unchanged in the first quarter. This mixed performance highlights both the strength of strategic investments and the challenges…
GNOLF Stock Plunges 98.99% on PNK: Genoil Inc. Faces Severe Decline
GNOLF stock crashes 98.99% to $0.0001 on PNK exchange. Genoil Inc. faces critical financial challenges with negative metrics.
ABBV Earnings Preview: AbbVie Q2 2026 on April 23
AbbVie earnings preview for April 23, 2026. Stock at $205.12 with B+ grade. Analyst consensus bullish with 19 buy ratings.